GlaxoSmithKline recently got a boost for fluticasone-furoate + vilanterol (Breo Ellipta), its new once-daily COPD maintenance inhaler.
Breo Ellipta beat usual care for COPD in real-world study
Breo Ellipta beat usual care for COPD in…
Breo Ellipta beat usual care for COPD in real-world study
GlaxoSmithKline recently got a boost for fluticasone-furoate + vilanterol (Breo Ellipta), its new once-daily COPD maintenance inhaler.